Description
BSE announces the upcoming listing and admission to trading of equity shares of Nephrocare Health Services Limited with scrip code 544647 and symbol NEPHROPLUS.
Summary
BSE has announced that equity shares of Nephrocare Health Services Limited will be listed and admitted to dealings on the Exchange in due course. The company has been assigned scrip code 544647, symbol NEPHROPLUS, and ISIN number INE428V01029. The exact listing date and security details will be communicated through a separate notice.
Key Points
- Company Name: Nephrocare Health Services Limited
- Scrip Code: 544647
- Trading Symbol: NEPHROPLUS
- ISIN Number: INE428V01029
- Listing status: To be listed in due course
- Specific listing date to be announced separately
Regulatory Changes
No regulatory changes. This is a standard listing announcement for a new company being admitted to the BSE platform.
Compliance Requirements
- Trading members are informed to note the company details for future trading operations
- Members should await the separate notice containing the exact listing date and security details before commencing trading
Important Dates
- Notice Date: December 16, 2025
- Listing Date: To be announced through separate notice
Impact Assessment
This is a routine listing announcement with minimal immediate market impact. Trading members of BSE are notified of the upcoming listing to prepare their systems and processes. The actual market impact will depend on the company’s business fundamentals, IPO pricing, and market conditions at the time of listing. Investors and traders should await the detailed listing notice before planning any trading activities in this security.
Impact Justification
Routine listing announcement for a single company with specific date to be notified later. Limited immediate market impact.